Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Valeant’s Medicis Sues Anacor Over Research Collaboration

Valeant Pharmaceuticals International Inc.’s Medicis unit, which makes drugs to treat skin conditions, sued Anacor Pharmaceuticals Inc. alleging violation of a collaborative research agreement.

Medicis wants a judge to force Anacor to comply with its contract and to issue “a permanent injunction against an improper arbitration,” according to papers filed in Delaware Chancery Court in Wilmington yesterday.

The complaint was filed under seal, with additional public information in other documents. Terms of the agreement weren’t specified. Palo Alto, California-based Anacor said in an Oct. 5 statement that it had a research-and-development agreement with Medicis to help discover small-molecule compounds to treat acne.

An Anacor spokeswoman, DeDe Sheel, didn’t immediately return a voice-mail message seeking comment on the dispute.

Valeant is based in Montreal, and Medicis is based in Scottsdale, Arizona.

The case is Medicis v. Anacor, CA8095, Delaware Chancery Court (Wilmington).

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.